| Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease | |
| Zhang, Lu; Zhao, Ai-lin; Duan, Ming-hui; Li, Zhi-yuan; Cao, Xin-xin; Feng, Jun; Zhou, Dao-bin; Zhong, Ding-rong; Fajgenbaum, David C.; Li, Jian | |
| 2019 | |
| 卷号 | 133期号:16页码:1720-1728 |
| ISSN号 | 0006-4971 |
| DOI | 10.1182/blood-2018-11-884577 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6343885 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhang, Lu,Zhao, Ai-lin,Duan, Ming-hui,et al. Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease[J],2019,133(16):1720-1728. |
| APA | Zhang, Lu.,Zhao, Ai-lin.,Duan, Ming-hui.,Li, Zhi-yuan.,Cao, Xin-xin.,...&Li, Jian.(2019).Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease.,133(16),1720-1728. |
| MLA | Zhang, Lu,et al."Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease".133.16(2019):1720-1728. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论